Vijay Balasubramanian1, Soe Naing. 1. Division of Pulmonary and Critical Care, Department of Medicine, UCSF Fresno, Fresno, California, USA. vbalasubramanian@fresno.ucsf.edu
Abstract
PURPOSE OF REVIEW: This review summarizes the literature on hypogonadism in men with chronic obstructive pulmonary disease (COPD). RECENT FINDINGS: COPD is a systemic disease with effects beyond the lungs. Many prior studies have shown that middle-aged and elderly COPD patients may develop hypogonadism. Prevalence of hypogonadism in men with COPD can range from 22 to 69% and has been associated with several other systemic manifestations including osteoporosis, depression, and muscle weakness. Recent studies have revealed conflicting results with regards to these previous perceptions. The discrepancies in the findings can be mainly attributed to small sample size, differences in patient selection, and inconsistent findings. Testosterone replacement therapy may result in modest improvements in fat-free mass and limb muscle strength but its therapeutic efficacy in COPD patients still remains controversial. SUMMARY: The relationship between hypogonadism and COPD still remains poorly understood. The current literature is at best circumstantial.
PURPOSE OF REVIEW: This review summarizes the literature on hypogonadism in men with chronic obstructive pulmonary disease (COPD). RECENT FINDINGS:COPD is a systemic disease with effects beyond the lungs. Many prior studies have shown that middle-aged and elderly COPDpatients may develop hypogonadism. Prevalence of hypogonadism in men with COPD can range from 22 to 69% and has been associated with several other systemic manifestations including osteoporosis, depression, and muscle weakness. Recent studies have revealed conflicting results with regards to these previous perceptions. The discrepancies in the findings can be mainly attributed to small sample size, differences in patient selection, and inconsistent findings. Testosterone replacement therapy may result in modest improvements in fat-free mass and limb muscle strength but its therapeutic efficacy in COPDpatients still remains controversial. SUMMARY: The relationship between hypogonadism and COPD still remains poorly understood. The current literature is at best circumstantial.
Authors: Javier de Miguel-Diez; Ana Lopez-de-Andres; Rodrigo Jimenez-Garcia; Jose M de Miguel-Yanes; Valentin Hernández-Barrera; David Carabantes-Alarcon; Jose J Zamorano-Leon; Marta Lopez-Herranz; Ricardo Omaña-Palanco Journal: Viruses Date: 2022-06-07 Impact factor: 5.818
Authors: Jacques Baillargeon; Rachel R Deer; Yong-Fang Kuo; Dong Zhang; James S Goodwin; Elena Volpi Journal: Mayo Clin Proc Date: 2016-04-06 Impact factor: 7.616
Authors: Sandeep Dhindsa; Nan Zhang; Michael J McPhaul; Zengru Wu; Amit K Ghoshal; Emma C Erlich; Kartik Mani; Gwendalyn J Randolph; John R Edwards; Philip A Mudd; Abhinav Diwan Journal: JAMA Netw Open Date: 2021-05-03
Authors: Elisabeth A P M Romme; Piet Geusens; Willem F Lems; Erica P A Rutten; Frank W J M Smeenk; Joop P W van den Bergh; Peter ThW van Hal; Emiel F M Wouters Journal: Respir Res Date: 2015-03-07
Authors: Joanna Miłkowska-Dymanowska; Adam J Białas; Anna Zalewska-Janowska; Paweł Górski; Wojciech J Piotrowski Journal: Int J Chron Obstruct Pulmon Dis Date: 2015-07-15